BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 36010915)

  • 1. The Roles of Immune Cells in Gastric Cancer: Anti-Cancer or Pro-Cancer?
    Sukri A; Hanafiah A; Kosai NR
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunology and immunotherapy in gastric cancer.
    Xu X; Chen J; Li W; Feng C; Liu Q; Gao W; He M
    Clin Exp Med; 2023 Nov; 23(7):3189-3204. PubMed ID: 37322134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune evasion mechanisms and therapeutic strategies in gastric cancer.
    Ma ES; Wang ZX; Zhu MQ; Zhao J
    World J Gastrointest Oncol; 2022 Jan; 14(1):216-229. PubMed ID: 35116112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy.
    Chung C
    Pharmacotherapy; 2017 Jan; 37(1):129-143. PubMed ID: 27870103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Progress and Future Perspectives of Immunotherapy in Advanced Gastric Cancer.
    Jin X; Liu Z; Yang D; Yin K; Chang X
    Front Immunol; 2022; 13():948647. PubMed ID: 35844558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor clinical outcomes of intratumoral dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin-positive macrophages associated with immune evasion in gastric cancer.
    Liu X; Cao Y; Li R; Gu Y; Chen Y; Qi Y; Lv K; Wang J; Yu K; Lin C; Liu H; Zhang H; He H; Chen L; Zhang P; Shen Z; Qin J; Sun Y; Li H; Huang H; Zhang W; Xu J
    Eur J Cancer; 2020 Mar; 128():27-37. PubMed ID: 32109848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy of pancreatic cancer.
    Sunami Y; Kleeff J
    Prog Mol Biol Transl Sci; 2019; 164():189-216. PubMed ID: 31383405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Pan-Cancer Crosstalk Between the
    Xie R; Yuan M; Jiang Y
    Front Cell Dev Biol; 2022; 10():790947. PubMed ID: 35309935
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment duration with immune-based therapies in Cancer: an enigma.
    Bantia S; Choradia N
    J Immunother Cancer; 2018 Dec; 6(1):143. PubMed ID: 30518409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress and prospects of immune checkpoint inhibitors in advanced gastric cancer.
    Zeng Z; Yang B; Liao Z
    Future Oncol; 2021 Apr; 17(12):1553-1569. PubMed ID: 33397136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing Hyperprogressive Disease in the Era of Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Blockade: A Case Discussion and Review of the Literature.
    Grecea M; Marabelle A; Ammari S; Massard C; Champiat S
    Oncologist; 2020 May; 25(5):369-374. PubMed ID: 32091646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer incidence and novel therapies developed in Japan.
    Iwasaki M
    J Stem Cells Regen Med; 2012; 8(3):203-4. PubMed ID: 24693199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple negative breast cancer - prognostic role of immune-related factors: a systematic review.
    Stovgaard ES; Nielsen D; Hogdall E; Balslev E
    Acta Oncol; 2018 Jan; 57(1):74-82. PubMed ID: 29168430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic gene modified cell based cancer vaccines.
    Kozłowska A; Mackiewicz J; Mackiewicz A
    Gene; 2013 Aug; 525(2):200-7. PubMed ID: 23566846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of chemotherapy combined with cytokine-induced killer cell /dendritic cell-cytokine-induced killer cell therapy for treatment of gastric cancer in China: A systematic review and meta-analysis.
    Mu Y; Zhou CH; Chen SF; Ding J; Zhang YX; Yang YP; Wang WH
    Cytotherapy; 2016 Sep; 18(9):1162-77. PubMed ID: 27421742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of PD-1 Blockade in Cancer Immunotherapy.
    Wu X; Gu Z; Chen Y; Chen B; Chen W; Weng L; Liu X
    Comput Struct Biotechnol J; 2019; 17():661-674. PubMed ID: 31205619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging role of natural products in cancer immunotherapy.
    Dong S; Guo X; Han F; He Z; Wang Y
    Acta Pharm Sin B; 2022 Mar; 12(3):1163-1185. PubMed ID: 35530162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of Cell-Cell Communication in Anaplastic Thyroid Cancer as an Immunotherapeutic Opportunity.
    Chakraborty S; Carnazza M; Jarboe T; DeSouza N; Li XM; Moscatello A; Geliebter J; Tiwari RK
    Adv Exp Med Biol; 2021; 1350():33-66. PubMed ID: 34888843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric Cancer and the Immune System: The Key to Improving Outcomes?
    Keshavjee SH; Moy RH; Reiner SL; Ryeom SW; Yoon SS
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-Cell Sequencing of Mouse Heart Immune Infiltrate in Pressure Overload-Driven Heart Failure Reveals Extent of Immune Activation.
    Martini E; Kunderfranco P; Peano C; Carullo P; Cremonesi M; Schorn T; Carriero R; Termanini A; Colombo FS; Jachetti E; Panico C; Faggian G; Fumero A; Torracca L; Molgora M; Cibella J; Pagiatakis C; Brummelman J; Alvisi G; Mazza EMC; Colombo MP; Lugli E; Condorelli G; Kallikourdis M
    Circulation; 2019 Dec; 140(25):2089-2107. PubMed ID: 31661975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.